Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.64 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.64 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.64 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.64 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24278832 | 0.84 | PTPN1 (0.54) | PTPN1PTPN2PTPN6PTPN11PABPC1 | |
| SCHEMBL24278619 | 0.83 | PTPN2 (0.52) | PTPN1PTPN2PTPN6PTPN11PABPC1 | |
| SCHEMBL24278718 | 0.80 | PTPN2 (0.56) | PTPN1PTPN2PTPN6PTPN11PABPC1 | |
| SCHEMBL24278808 | 0.80 | PTPN2 (0.56) | PTPN1PTPN2PTPN6PTPN11PABPC1 | |
| SCHEMBL11048124 | 0.80 | PTPN2 (0.56) | PTPN1PTPN2PTPN6PTPN11PABPC1 | |
| SCHEMBL27857310 | 0.79 | PTPN2 (0.69) | PTPN1PTPN2PTPN6PTPN11PABPC1 | |
| SCHEMBL24278710 | 0.79 | PTPN2 (0.49) | PTPN1PTPN2PTPN6PTPN11PABPC1 | |
| SCHEMBL27105237 | 0.78 | PTPN2 (0.58) | PTPN1PTPN2PTPN6PTPN11PABPC1 | |
| SCHEMBL24278560 | 0.78 | PTPN2 (0.57) | PTPN1PTPN2PTPN6PTPN11PABPC1 | |
| SCHEMBL17922016 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240067764-A1 | SOLID TITANIUM CATALYST COMPONENT, OLEFIN POLYMERIZATION CATALYST, OLEFIN POLYMERIZATION METHOD, AND PROPYLENE POLYMER | MITSUI CHEMICALS, INC. (JP) | 2024-02-29 | — | — | US | disclosed |
| US-20240067764-A1 | SOLID TITANIUM CATALYST COMPONENT, OLEFIN POLYMERIZATION CATALYST, OLEFIN POLYMERIZATION METHOD, AND PROPYLENE POLYMER | MITSUI CHEMICALS, INC. (JP) | 2024-02-29 | — | — | US | disclosed |
| US-20240067597-A1 | ESTER COMPOUND | MITSUI CHEMICALS, INC. (JP) | 2024-02-29 | — | — | US | disclosed |
| US-20240067597-A1 | ESTER COMPOUND | MITSUI CHEMICALS, INC. (JP) | 2024-02-29 | — | — | US | disclosed |
| EP-4269450-A1 | SOLID TITANIUM CATALYST COMPONENT, OLEFIN POLYMERIZATION CATALYST, OLEFIN POLYMERIZATION METHOD, AND PROPYLENE POLYMER | Mitsui Chemicals, Inc. (JP) | 2023-11-01 | — | — | EP | disclosed |
| EP-4265593-A1 | ESTER COMPOUND | Mitsui Chemicals, Inc. (JP) | 2023-10-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240067597-A1 | ESTER COMPOUND | PPT1, GPER1, TCP1 | PTPN1 3803/4885PTPN2 4255/4885PTPN6 4606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.